Rebalix
Xtrackers · sheet of 10 September 2026
Xtrackers · sheet of 10 September 2026ETF sheet · official issuer and register data
Xtrackers Stoxx Europe 600 UCITS ETF 1d
LU2581375156 · LU2581375156 · EUR · domicile Luxembourg
Equity · EuropeSFDR art. 6 (inferred)
Index tracked: STOXX® Europe 600 INDEX (EUR)
- TER
- 0.07%+ trans. 0.01%
- Fund size
- 5.7 bn EUR
- Tracking difference
- —not computable
- 🇮🇹 tax rate
- —white list not published
- Replication
- Physical
- Income
- Distributingquarterly
Launch 8 Mar 2023 · costs from the KID as of 2 Sept 2026 · 615 securities held · 8 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
The fund is passively managed.
INVESTMENT OBJECTIVE:
The aim is for your investment to reflect the performance of the STOXX® Europe 600 Index (index) which is designed to reflect the performance of shares of 600 companies in Western Europe.
DESCRIPTION OF INDEX:
The index contains shares of large, medium and small companies, based on the combined value of a company’s readily available shares compared to other companies. A company’s weighting in the index depends on its relative size but cannot exceed 20% of the index at each quarterly review. The…
Performance since series start (in euro) — base 100
8 Mar 2023 → 8 Sept 2026 · dividends reinvested where declared by the issuer
Returns in euro
| 1 year | +21.6% |
| 3 years | +55.7% |
| 5 years | series too young |
| 10 years | series too young |
| Since series start | +57.1% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 12.15% | 12.41% | — |
| Max drawdown | −9.37% | −16.17% | — |
| Sharpe | 1.21 | 0.74 | — |
| Sortino | 1.84 | 1.03 | — |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · LU2581375156 · LU25813751561
RebalixLU2581375156 · LU2581375156 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · from issuer-declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +20.18% | +19.80% | +0.38% |
| 2024 | +9.11% | +8.79% | +0.32% |
Distributions · per share, in EUR
Frequency: quarterly · last 12 months: 2.5826 EUR (2.57% of NAV) · last ex-date 19 Aug 2026
| Year | Payments | Total (EUR) | Dividend yield |
|---|---|---|---|
| 2026 | 3 | 2.267 | — |
| 2025 | 4 | 2.4527 | +3.13% |
| 2024 | 4 | 2.5889 | +3.49% |
| 2023 | 2 | 1.6738 | — |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Holdings
Portfolio as declared by the issuer · 2 Sept 2026 · 615 securities · top-10 weight = 19.4%
| Top holdings | Weight |
|---|---|
| 4.1% | |
| 2.3% | |
| 2.0% | |
| 1.9% | |
| 1.7% | |
| 1.6% | |
| 1.6% | |
| 1.5% | |
| 1.4% | |
| 1.4% |
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
XSX7 · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 19 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/LU2581375156
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/LU2581375156
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · LU2581375156 · LU25813751562